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Sir,
We read the interesting article by Lawes et al (2005) on the role
of MLH1, MSH2 and MSH6 in the development of multiple
colorectal cancers in the general population. They suggested that,
although MSI-H is more commonly identified in those with
multiple colorectal cancers, this does not commonly arise from a
classical HNPCC pathway. Also, unlike HNPCC cancers, they
showed the heterogeneity of the MSI status between multiple
cancers within each individual in the general population. In
HNPCC, about 90% of cancers show MSI. On the other hand, of the
32 patients from whom two or more cancers were analysed in
Lawes’s study, eight (25%) demonstrated MSI-H in both cancers,
13 (41%) demonstrated MSI-H in one cancer and 11 (34%) failed
to demonstrate any MSI-H. Although they examined only cancer
lesions, we have performed a similar research for patients with
multiple colorectal cancers and we further examined the MSI
status in adenomas as well as cancers (Ueda et al, 2002). Including
adenomas, we could show that the MSI status differs between
tumours within each individual. Among 13 patients with multiple
colorectal cancers, there was only one patient (7.7%), whose
cancers and adenomas showed the same MSI status. In the rest of
12 patients, the MSI status differed between cancers and
adenomas. These results confirm that neoplastic lesions in patients
with multiple colon cancers in the general population do not
develop in the same pathway as HNPCC. In HNPCC, not only
cancers but also adenomas are known to show high frequency of
MSI (Watanabe et al, 1996; Velayos et al, 2005).
Lawes et al also pointed out an importance of methylation of the
MLH1 promoter region in the development of MSI-H cancers
among patients with multiple colorectal cancers. In our analysis, in
addition to MLH1, we further examined the methylation status of
four more markers (p16, MINT1, MINT2, MINT 31) and classified
tumours into CpG island methylator phenotype (CIMP), either
CIMP-High or CIMP-Low (Tada et al, 2003). Methylation of
hMLH1 was observed in 54% (24 out of 44) of all tumours and 78%
(seven out of nine) of MSI-H tumours. CIMP-High was observed in
26% (12 out of 46) and CIMP-Low in 43% (20 out of 46) of
tumours. The overall frequency of CIMP was 70% (32 out of 46) in
multiple colorectal cancers, and our study demonstrated that
multiple cancers show a high frequency of CIMP.
Considering that CIMP tumours develop due to epigenetic
changes of various genes, our results, together with Lawes’s results,
suggest that epigenetic changes play an important role in the
development of multiple primary cancers in the general population.
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